Question 1

How big is the Global Liquid Biopsy market?

Accepted Answer

According to Value Market Research, the global Global Liquid Biopsy market size was estimated at USD 6.78 Billion in 2025 and is expected to reach USD 7.61 Billion in 2026.

Question 2

What is the Global Liquid Biopsy market growth?

Accepted Answer

The global Global Liquid Biopsy market is expected to grow at a CAGR of 12.28% from 2026-2034 to reach USD 19.23 Billion by 2034.

Question 3

Which region holds the highest share in the Global Liquid Biopsy market?

Accepted Answer

North America held the highest share in the global Global Liquid Biopsy market.

Question 4

How is the Global Liquid Biopsy market segmented in the report?

Accepted Answer

The Global Liquid Biopsy market is segmented By Product (Consumables (Kits and Reagents, Assays and Panels), Instruments, Services), By Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Cell-Free DNA (cfDNA), Extracellular Vesicles, Other Biomarkers), By Disease Indication (Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Other Cancers), Non-Cancer (Non-Invasive Prenatal Testing, Organ Transplantation, Infectious Disease Testing)), By Clinical Application (Treatment Monitoring, Prognosis and Recurrence Monitoring, Treatment Selection, Diagnosis and Screening), By Technology (Multi-Gene Parallel Analysis (NGS), Single-Gene Analysis (PCR, Microarrays)), By End User (Hospitals, Research Laboratories, Clinical Laboratories, Other End Users).

Question 5

Which segment accounted for the largest liquid biopsy market share?

Accepted Answer

The multi-gene parallel analysis (NGS) segment dominated the market with a 77.98% share in 2025, driven by its ability to simultaneously analyse multiple genomic alterations with high accuracy and support precision oncology.

Question 6

What are the factors driving the liquid biopsy market?

Accepted Answer

Key drivers include increasing global cancer incidence, expanding adoption of precision medicine, continuous advancements in next generation sequencing technologies, growing regulatory approvals for companion diagnostics, and rising demand for minimally invasive diagnostic solutions across oncology and non-oncology applications.

Question 7

Who are the key players in the Global Liquid Biopsy market?

Accepted Answer

Some key players include ANGLE plc, Biocept, Bio-Rad Laboratories, Epigenomics AG and F. Hoffmann-La Roche.